Close Menu

NEW YORK (GenomeWeb) – BioGx announced today that UK-based firm Launch Diagnostics will distribute assay products from BioGx's European-based subsidiary in the UK and Ireland.

As part of the multi-year partnership, Launch Diagnostics will collaborate with the Netherlands subsidiary of Birmingham, Alabama-based BioGx to distribute its CE-IVD-marked product line for infectious diseases, in addition to laboratory-use-only products, Template Positive Controls, and ValidPaks to expedite customer validation studies.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The UK and the European Union have come to a sticking point in the negotiation of how the UK might remain involved in the Horizon Europe research program, the Guardian reports.

The New York Times reports that experts pushed during a meeting of an FDA advisory board for the agency to require more safety data from SARS-CoV-2 vaccine trials.

The Washington Post reports Moderna expects that it will have enough data on its candidate SARS-CoV-2 vaccine to submit to regulatory authorities by mid-November.

In Science this week: ANXA11 variants affect calcium homeostasis and stress granule disassembly in ALS, and more.